Добро пожаловать
Зарегистрировать аккаунт
Войдите, используя email
Зарегистрируйтесь с помощью email
Проверь свои входящие
Structure Therapeutics
About
Structure Therapeutics specializes in the discovery and development of drugs against a type of targets called GPCR.
- 51 - 100
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $100M
- Industries
- Biotechnology,Health Care,Medical,Pharmaceutical,Product Research
- Founded date
- Jan 1, 2016
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Structure Therapeutics creates life-changing medicines for patients using advanced computational and structure-based technology. Our platform combines the latest advancements in computational chemistry, visualization of molecular interactions, and data integration to design orally available, superior medicines that overcome current limitations in biologic and peptide drugs. We are advancing our clinical-stage pipeline of differentiated, efficacious and safe treatments focused on chronic diseases with high unmet need, including cardiovascular, metabolic and pulmonary conditions. At Structure, our team’s deep experience with complex biological targets and mechanisms, structure-based drug design, and global drug discovery and development enables our bold vision: to design and develop world-class medicines with tremendous patient impact and broad commercial opportunity.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 1, 2022 | Series B | $33M | 1 | — | — | Detail |
| Oct 20, 2021 | Series B | $100M | 2 | — | — | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series B |
Schrödinger
|
— | Series B |
Lilly Asia Ventures
|
— | Series B |
